Immunohistochemical profile of ephrin A4 expression in human osteosarcoma

APMIS

Volumn 117, Issue 4, 2009, Pages 277-285

  Abdou, Asmaa Gaber ^a   El Wahed, Moshira Mohammed Abd ^a   Asaad, Nancy Youssef ^a   Samaka, Rehab Monir ^a   Abdallaha, Rania ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Ephrin A4; Osteosarcoma; Pattern of staining

Indexed keywords

EPHRIN A4;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE METASTASIS; BONE TISSUE; CANCER INVASION; CELL NUCLEUS; CHILD; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG METASTASIS; MALE; OSTEOSARCOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CHILD; EPHRIN-A4; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; OSTEOSARCOMA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 63449131772     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2009.02448.x     Document Type: Article

References (34)

1. Mokhtar N, Gouda I, Adel I. Malignant bone tumors. In : Mokhtar N, Gouda I, Adel I, editors. Cancer Pathology Registry 2003-2004 and Timed Trend Analysis, 11, 1st ed. Cairo : NCI, Elsheraa Press, 2007 : 88 9.
2. Picci P. Osteosarcoma (Osteogenic sarcoma). Orphanet J Rare Dis 2007 2 : 6.
3. Iiizumi M, Hosokawa M, Takehara A, Chung S, Nakamura T, Katagiri T, et al. EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth. Cancer Sci 2006 97 : 1211 6.
4. Surawska H, Ma PC, Salgia R. The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev 2004 15 : 419 33.
5. Hafner C, Schmitz G, Meyer S, Bataille F, Hau P, Langmann T, et al. Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin Chem 2004 50 : 490 9.
6. Nakada M, Niska JA, Miyamori H, McDonough WS, Wu J, Sato H, et al. The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells. Cancer Res 2004 64 : 3179 85.
7. Xia G, Kumar SR, Masood R, Zhu S, Reddy R, Krasnoperov V, et al. EphB4 expression and biological significance in prostate cancer. Cancer Res 2005 65 : 4623 32.
8. Berclaz G, Flütsch B, Altermatt HJ, Rohrbach V, Djonov V, Ziemiecki A, et al. Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast. Oncol Rep 2002 9 : 985 9.
9. Berclaz G, Karamitopoulou E, Mazzucchelli L, Rohrbach V, Dreher E, Ziemiecki A, et al. Activation of the receptor protein tyrosine kinase EphB4 in endometrial hyperplasia and endometrial carcinoma. Ann Oncol 2003 14 : 220 6.
10. Abraham S, Knapp DW, Cheng L, Snyder PW, Mittal SK, Bangari DS, et al. Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary Bladder. Clin Cancer Res 2006 12 : 353 60.
11. Kataoka H, Tanaka M, Kanamori M, Yoshii S, Ihara M, Wang YJ, et al. Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancer. J Cancer Res Clin Oncol 2002 128 : 343 8.
12. Jubb AM, Zhong F, Bheddah S, Grabsch HI, Frantz GD, Mueller W, et al. EphB2 is a prognostic factor in colorectal cancer. Clin Cancer Res 2005 11 : 5181 7.
13. Khan MS, Dodson AR, Heatley MK. Ki-67, oestrogen receptor, and progesterone receptor proteins in the human rete ovarii and in endometriosis. J Clin Pathol 1999 52 : 517 20.
14. Varelias A, Koblar SA, Cowled PA, Carter CD, Clayer M. Human osteosarcoma expresses specific ephrin profiles implications for tumorigenicity and prognosis. Cancer 2002 95 : 862 9.
15. Zhao C, Irie N, Takada Y, Shimoda K, Miyamoto T, Nishiwaki T, et al. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab 2006 4 : 111 21.
16. Allan EH, Häusler KD, Wei T, Gooi JH, Quinn JM, Crimeen-Irwin B, et al. EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts. J Bone Miner Res 2008 23 : 1170 81.
17. Hunter SG, Zhuang G, Brantley-Sieders D, Swat W, Cowan CW, Chen J. Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis. Mol Cell Biol 2006 26 : 4830 42.
18. Cheng N, Brantley D, Fang WB, Liu H, Fanslow W, Cerretti DP, et al. Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors1 inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors. Neoplasia 2003 5 : 445 56.
19. Ogawa K, Pasqualini R, Lindberg RA, Kain R, Freeman AL, Pasquale EB. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene 2000 19 : 6043 52.
20. Sawai Y, Tamura S, Fukui K, Ito N, Imanaka K, Saeki A, et al. Expression of ephrin-B1 in hepatocellular carcinoma: possible involvement in neovascularization. J Hepatol 2003 39 : 991 6.
21. Dottori M, Down M, Huttmann A, Fitzpatrick DR, Boyd AW. Cloning and characterization of EphA3 (Hek) gene promoter: DNA methylation regulates expression in hematopoietic tumor cells. Blood 1999 94 : 2477 86.
22. Larsen AB, Pedersen MW, Stockhausen MT, Grandal MV, van Deurs B, Poulsen HS. Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility. Mol Cancer Res 2007 5 : 283 93.
23. Carpenter G. Nuclear localization and possible function of receptor tyrosine kinases. Curr Opin Cell Biol 2003 15 : 143 8.
24. Lo HW, Xia W, Wei Y, Ali-Seyed M, Huang SF, Hung MC. Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Res 2005 65 : 338 48.
25. Ilan N, Tucker A, Madri JA. Vascular endothelial growth factor expression, beta-catenin tyrosine phosphorylation, and endothelial proliferative behavio: a pathway for transformation? Lab Invest 2003 83 : 1105 15.
26. Stachowiak EK, Fang X, Myers J, Dunham S, Stachowiak MK. cAMP-induced differentiation of human neuronal progenitor cells is mediated by nuclear fibroblast growth factor receptor-1 (FGFR1). J Neurochem 2003 84 : 1296 312.
27. Giri DK, Ali-Seyed MA, Li LY, Lee DF, Ling P, Bartholomeusz G, et al. Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor. Mol Cell Biol 2005 25 : 11005 18.
28. Bouyain S, Longo PA, Li S, Ferguson KM, Leahy DJ. The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand. Proc Natl Acad Sci USA 2005 102 : 15024 9.
29. Sorkin A, Von Zastrow M. Signal transduction and endocytosis: close encounters of many kinds. Nat Rev Mol Cell Biol 2002 3 : 600 14.
30. Miaczynska M, Pelkmans L, Zerial M. Not just a sink: endosomes in control of signal transduction. Curr Opin Cell Biol 2004 16 : 400 6.
31. Herath NI, Spanevello MD, Sabesan S, Newton T, Cummings M, Duffy S, et al. Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival. BMC Cancer 2006 6 : 144.
32. Bacci G, Longhi A, Versari M, Briccoli A, Picci P. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 2006 106 : 1154 61.
33. Masood R, Xia G, Smith DL, Scalia P, Still JG, Tulpule A, et al. Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium. Blood 2005 105 : 1310 8.
34. Kumar SR, Singh J, Xia G, Krasnoperov V, Hassanieh L, Ley EJ, et al. Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol 2006 169 : 279 93.